Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its target price lifted by investment analysts at UBS Group from $500.00 to $560.00 in a note issued to investors on Monday. The brokerage currently has a “neutral” rating on the medical equipment provider’s stock. UBS Group’s target price indicates a potential downside of 2.46% from the company’s current price.
ISRG has been the topic of several other research reports. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Piper Sandler restated an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.
View Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Stock Performance
Insiders Place Their Bets
In other news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,749 shares of company stock worth $15,303,875 over the last quarter. 0.90% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. Martin Capital Advisors LLP grew its stake in Intuitive Surgical by 4.3% in the 4th quarter. Martin Capital Advisors LLP now owns 20,206 shares of the medical equipment provider’s stock worth $10,547,000 after buying an additional 825 shares in the last quarter. LJI Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 1.8% in the 4th quarter. LJI Wealth Management LLC now owns 1,161 shares of the medical equipment provider’s stock worth $606,000 after purchasing an additional 21 shares in the last quarter. Focused Wealth Management Inc bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $218,000. 17 Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. 17 Capital Partners LLC now owns 1,851 shares of the medical equipment provider’s stock valued at $966,000 after buying an additional 35 shares in the last quarter. Finally, Kestra Private Wealth Services LLC boosted its stake in Intuitive Surgical by 9.1% in the fourth quarter. Kestra Private Wealth Services LLC now owns 45,518 shares of the medical equipment provider’s stock worth $23,759,000 after buying an additional 3,809 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- The 3 Best Blue-Chip Stocks to Buy Now
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- What Does the Future Hold for Eli Lilly?
- 3 Small Caps With Big Return Potential
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.